ArticleInflammatory bowel diseases2022

Mesalazine in Inflammatory Bowel Disease and COVID-19: Hospitalization and Adverse In-Hospital Outcomes Based on Nationwide Data.

Simon Kjeldsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.